BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.8% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
BeOne Medicines Ltd
ONC
$46B
| $198M | ﹤0.01% |
694,618
+37,117
| +6% | +$10.9M |
2016 Q1
41 quarters
|
|
1802
Edgewell Personal Care
EPC
$1.29B
| $198M | ﹤0.01% |
7,354,533
-7,452
| -0.1% | -$159K |
2013 Q2
52 quarters
|
|
1803
Syndax Pharmaceuticals
SNDX
$859M
| $197M | ﹤0.01% |
9,020,006
+765,580
| +9% | +$15.9M |
2016 Q1
41 quarters
|
|
1804
Collegium Pharmaceutical
COLL
$788M
| $197M | ﹤0.01% |
5,441,202
+307,175
| +6% | +$10.5M |
2016 Q1
41 quarters
|
|
1805
Biohaven
BHVN
$2.19B
| $197M | ﹤0.01% |
13,210,585
+1,988,178
| +18% | +$21.4M |
2022 Q4
14 quarters
|
|
1806
Redwire
RDW
$1.8B
| $197M | ﹤0.01% |
16,068,161
+4,994,728
| +45% | +$65.9M |
2021 Q4
18 quarters
|
|
1807
QuidelOrtho
QDEL
$734M
| $196M | ﹤0.01% |
11,202,523
+753,396
| +7% | +$10M |
2013 Q2
52 quarters
|
|
1808
On Holding
ONON
$12.5B
| $196M | ﹤0.01% |
5,535,923
-227,339
| -4% | -$8.31M |
2021 Q3
19 quarters
|
|
1809
Veradermics Inc
MANE
$5.8B
| $196M | ﹤0.01% |
1,593,791
+1,311,180
| +464% | +$123M |
2026 Q1
1 quarter
|
|
1810
Westamerica Bancorp
WABC
$1.38B
| $196M | ﹤0.01% |
3,335,703
-113,632
| -3% | -$6.29M |
2013 Q2
52 quarters
|
|
1811
Snap
SNAP
$8.39B
| $195M | ﹤0.01% |
44,007,270
-3,252,868
| -7% | -$17.8M |
2017 Q1
37 quarters
|
|
1812
Upbound Group
UPBD
$1.41B
| $194M | ﹤0.01% |
9,152,511
+944,446
| +12% | +$17.7M |
2013 Q2
52 quarters
|
|
1813
OceanFirst Financial
OCFC
$1.79B
| $194M | ﹤0.01% |
9,940,366
+3,206,812
| +48% | +$59.8M |
2013 Q2
52 quarters
|
|
1814
Huntsman Corp
HUN
$1.66B
| $194M | ﹤0.01% |
18,243,856
+5,593,887
| +44% | +$77.1M |
2013 Q2
52 quarters
|
|
1815
Tompkins Financial
TMP
$1.43B
| $194M | ﹤0.01% |
2,049,724
+47,391
| +2% | +$4.08M |
2013 Q2
52 quarters
|
|
1816
Newmark Group
NMRK
$2.16B
| $194M | ﹤0.01% |
12,818,674
+615,347
| +5% | +$9.4M |
2018 Q1
33 quarters
|
|
1817
STAAR Surgical
STAA
$1.26B
| $193M | ﹤0.01% |
6,731,154
+65,036
| +1% | +$1.81M |
2013 Q2
52 quarters
|
|
1818
Baldwin Insurance Group
BWIN
$4.5B
| $193M | ﹤0.01% |
7,251,950
+600,650
| +9% | +$13M |
2019 Q4
26 quarters
|
|
1819
Stepan Co
SCL
$1.52B
| $193M | ﹤0.01% |
3,458,328
+147,288
| +4% | +$7.66M |
2013 Q2
52 quarters
|
|
1820
SAP
SAP
$269B
| $193M | ﹤0.01% |
1,249,520
+96,424
| +8% | +$16.4M |
2020 Q2
24 quarters
|
|
1821
Stoke Therapeutics
STOK
$1.72B
| $192M | ﹤0.01% |
5,877,357
+491,643
| +9% | +$15.8M |
2019 Q2
28 quarters
|
|
1822
Azenta
AZTA
$1.72B
| $192M | ﹤0.01% |
7,529,450
+804,461
| +12% | +$18M |
2013 Q2
52 quarters
|
|
1823
Integra LifeSciences
IART
$1.04B
| $192M | ﹤0.01% |
10,684,103
+364,934
| +4% | +$5.1M |
2013 Q2
52 quarters
|
|
1824
iShares US Aerospace & Defense ETF
ITA
$4.02B
| $191M | ﹤0.01% |
2,359,920
+203,499
| +9% | +$15.4M |
2025 Q3
3 quarters
|
|
1825
Ocular Therapeutix
OCUL
$1.45B
| $190M | ﹤0.01% |
19,376,555
+3,243,624
| +20% | +$29.4M |
2015 Q2
44 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 245 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 245 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.